期刊文献+

^(177)Lu-DOTA/DTPA-Bz-Cys-RGD dimer的制备及正常鼠体内生物分布 被引量:3

Preparation of ^(177)Lu-DOTA/DTPA-Bz-Cys-RGD Dimer and Biodistribution Evaluation in Normal Mice
下载PDF
导出
摘要 制备177Lu-DOTA-Bz-Cys-RGD dimer和177Lu-DTPA-Bz-Cys-RGD dimer,并对其体内外性质进行比较。TLC和HPLC分析结果表明,在pH=5.0和100℃条件下反应15~20 min,2种标记物的标记率均大于95%,并且在室温条件下2种标记物均保持良好的体外稳定性。HPLC分析结果和脂水分配系数lgP测定结果证实,177Lu-DOTA-Bz-Cys-RGD dimer的脂溶性高于177Lu-DTPA-Bz-Cys-RGD dimer。生物分布实验数据显示,注射后4 h,除了血液和脾,177Lu-DTPA-Bz-Cys-RGD dimer在其它组织中的摄取明显高于177Lu-DOTA-Bz-Cys-RGD dimer,177Lu-DOTA-Bz-Cys-RGD dimer的体内稳定性远好于177Lu-DTPA-Bz-Cys-RGD dimer。Bz-DOTA更适于作为双功能螯合剂用于RGD dimer的177Lu标记。 ^177Lu-DOTA-Bz-Cys-RGD dimer and 177LuDTPA-Bz-Cys-RGD dimer were prepared,and the in vitro and in vivo properties were compared.TLC and HPLC show that the labeling yields of two radiolabeled compounds are more than 95% under optimal conditions(pH=5.0,reacting at 100 ℃ for 15-20 min),and the two radiolabeled compounds show pretty good in vitro stability.HPLC analyses and lg P values reveal that lipophilicity of ^177Lu-DOTA-Bz-Cys-RGD dimer is higher than ^177Lu-DTPA-Bz-Cys-RGD dimer.The uptake of ^177Lu-DTPA-Bz-Cys-RGD dimer is other tissues is significantly higher than that of ^177Lu-DOTA-Bz-Cys-RGD dimer at 4h postinjection,except for blood and spleen.The in vivo stability of ^177Lu-DOTA-Bz-Cys-RGD dimer is much better than ^177Lu-DOTA-Bz-Cys-RGD dimer.Bz--DOTAis an ideal bifunctional chelator for ^177Lu labeling of RGD dimer.
出处 《核化学与放射化学》 EI CAS CSCD 北大核心 2008年第2期70-74,共5页 Journal of Nuclear and Radiochemistry
基金 国家自然科学基金资助项目(30640067)
关键词 RGD二聚体 ^177Lu DOTA DTPA 生物分布 RGD dimer 177Lu DOTA DTPA biodistribution
  • 相关文献

参考文献16

  • 1Carmeliet P. Angiogenesis in Health and Disease [J]. Nat Med, 2003, 9: 653-660.
  • 2Folkman J. Tumor Angiogenesis: Therapeutic Implications[J]. New Eng J Med, 1971, 285: 1182-1186.
  • 3Brooks P C, Clark R A, Cheresh D A. Requirement of Vascular Integrin αvβ3 for Angiogenesis[J]. Science, 1994, 264: 569-571.
  • 4Ruoslahti E. Specialization of Tumour Vasculature [J]. Nat Rev Cancer, 2002, 2: 83-90.
  • 5Sengupla S, Chattopadhyay N, Mitra A, et al. Role of αvβ3 Integrin Receptors in Breast Tumor[J]. J Exp Clin Cancer Res, 2001, 20: 585-590.
  • 6Zitzmann S, Ehemann V, Schwab M. Arginine-Glycine-Aspartic Acid (RGD)-Peptide Binds to Both Tumor and Tumor Endothelial Cells in Vivo [J]. Cancer Res, 2002, 62:5139-5143.
  • 7Pasqualini R, Koivunen E, Ruoslahti E. Alpha v Integrins as Receptors for Tumor Targeting by Circulating Ligands[J]. Nat Biotechnol, 1997, 15: 542-546.
  • 8Haubner R, Wester H J, Reuning U, et al. Radiolabeled αvβ3 Integrin Antagonists: A New Class of Tracers for Tumor Imaging[J]. J Nucl Med, 1999, 40:1061-1071.
  • 9Haubner R, Wester H J, Burkhart F, et al. Glycolated RGD-Containing Peptides: Tracer for Tumor Targeting and Angiogenesis Imaging With Improved Biokinetics[J]. J Nucl Med, 2001, 42: 326-336.
  • 10Marcel L J, Wim J O, Ingrid D, et al. Tumor Targeting With Radiolabeled αvβ3 Integrin Binding Peptides in a Nude Mouse Model[J]. Cancer Res, 2002,62:6146-6151.

同被引文献54

  • 1李伟.iTRAQ多重化学标记串联质谱技术在比较蛋白质组学中的应用[J].生命的化学,2006,26(5):453-456. 被引量:8
  • 2钱林艺,应万涛,刘新,卢庄,蔡耘,何建勇,钱小红.^(18)O稳定同位素标记定量蛋白质组研究技术的建立与优化[J].分析化学,2007,35(2):161-165. 被引量:9
  • 3刘昭飞,贾兵,史继云,杨志,赵慧云,王凡.^(99)Tc^m-RGD环肽二聚体的制备及其体内外评价[J].中华核医学杂志,2007,27(4):205-209. 被引量:18
  • 4Carmeliet P. Angiogenesis in health and disease. Nat Med, 2003,9: 653-660.
  • 5Sun Y,Wang JW, Liu Y,et al. Results of phase]H trial of rh-en-dostatin ( YH-16) in advanced non-small lung cancer ( NSCLC )patients. Proc Asco, 2005, 23: 7138.
  • 6Kim YM, Hwang S, Kim YM, et al. Endostatin blocks vascularendothelial growth factor-mediated signaling via direct interactionwith KDR/Flk-1. J Biol Chem, 2002,277: 27872-27879.
  • 7Liu S. Radiolabeled multimeric cyclic RGD peptides as integrinavp3 targeted radiotracer for tumor imaging. Mol Pharm, 2006, 3:472-487.
  • 8Wheatley MA,Lathia JD,Oum KL. Polymeric ultrasound contrastagents targeted to integrins : importance of process methods and sur-face density of ligands. Biomacromolecules, 2007,8: 516-522.
  • 9Ellegala DB, Leong-Poi H, Carpenter JE, et al. Imaging tumor an-giogenesis with contrast ultrasound and microbubbles targeted toavp3. Circulation, 2003, 108: 336-341.
  • 10Cai W, Gambhir SS,Chen X. Chapter T. Molecular imaging of tumorvasculature. Methods Enzymol, 2008 , 445: 141-176.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部